KALISPELL REGIONAL MEDICAL CENTER
- Type
- Teaching hospital
- Where
- Kalispell, MT
- Medicare CCN
- 270051
- Received
- $1,049,688 in 650 records, 2019 ($56,728 general, $992,959 research)
- Source
- CMS Open Payments search ↗
On this site
- Business registration: Kalispell Regional Medical Center, Inc. Fuzzy (name and state)
- Business registration: Kalispell Regional Medical Center, Inc. Fuzzy (name and state)
- Business registration: KALISPELL REGIONAL MEDICAL CENTER, INC. Fuzzy (name and state)
- Business registration: KALISPELL REGIONAL MEDICAL CENTER, INC. Fuzzy (name and state)
- Nonprofit contractor: KALISPELL REGIONAL MEDICAL CENTER Fuzzy (name and state)
- Federal award recipient: KALISPELL REGIONAL MEDICAL CENTER INC Fuzzy (name and state)
- Lobbying client: KALISPELL REGIONAL MEDICAL CENTER Fuzzy (name and state)
- Lobbying client: KALISPELL REGIONAL MEDICAL CENTER Fuzzy (name and state)
- Lobbying client: KALISPELL REGIONAL MEDICAL CENTER Fuzzy (name and state)
- Nonprofit: KALISPELL REGIONAL MEDICAL CENTER INC Fuzzy (name and state)
- Trademark owner: Kalispell Regional Medical Center, Inc. Fuzzy (name and state)
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2019 | General payment | 66 | $56,728 |
| 2019 | Research payment | 584 | $992,959 |
By company
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Research payment | 584 | $992,959 |
| Space rental or facility fees (teaching hospital only) | 17 | $18,750 |
| Gift | 4 | $15,059 |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a v | 40 | $12,618 |
| Grant | 4 | $8,800 |
| Education | 1 | $1,500 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2019-12-31 | Medartis Inc. | $7,860 | Gift (2 payments) | In-kind items and services | APTUS Device, ORTHO | 2019 | |
| 2019-12-30 | Tandem Diabetes Care, Inc. | $400 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | t-slim insulin pump Device, Endocrinology | 2019 | |
| 2019-12-24 | Amgen Inc. | $1,340 | Research payment | Cash or cash equivalent | Repatha Biological, Cardiology | FOURIER OLE (Ph 4) | 2019 |
| 2019-12-20 | ABBVIE INC. | $3,865 | Research payment | Cash or cash equivalent | Rinvoq Biological, Immunology | M15-572 | 2019 |
| 2019-12-19 | Sterilmed, Inc. | $359 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2019 | ||
| 2019-12-17 | Kowa Research Institute, Inc. | $1,511 | Research payment | Cash or cash equivalent | Drug | K-877-302 | 2019 |
| 2019-12-12 | CSL Behring | $4,163 | Research payment | Cash or cash equivalent | Study to Investigate CSL112 in Subjects With Acute Coronary Syndrome AEGIS-II | 2019 | |
| 2019-12-11 | Tandem Diabetes Care, Inc. | $250 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | t-slim insulin pump Device, Endocrinology | 2019 | |
| 2019-12-10 | Incyte Corporation | $3,521 | Research payment | Cash or cash equivalent | PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBRO | 2019 | |
| 2019-12-10 | BIOTRONIK INC. | $414 | Research payment | Cash or cash equivalent | Sentus Device, Cardiology/Vascular Diseases | QP ExCELs | 2019 |
| 2019-12-10 | BIOTRONIK INC. | $299 | Research payment | Cash or cash equivalent | BIO-LIBRA | 2019 | |
| 2019-12-10 | BIOTRONIK INC. | $299 | Research payment | Cash or cash equivalent | BIO-LIBRA | 2019 | |
| 2019-12-10 | BIOTRONIK INC. | $289 | Research payment | Cash or cash equivalent | Sentus Device, Cardiology/Vascular Diseases | QP ExCELs | 2019 |
| 2019-12-10 | BIOTRONIK INC. | $289 | Research payment | Cash or cash equivalent | Sentus Device, Cardiology/Vascular Diseases | QP ExCELs | 2019 |
| 2019-12-10 | BIOTRONIK INC. | $289 | Research payment | Cash or cash equivalent | Sentus Device, Cardiology/Vascular Diseases | QP ExCELs | 2019 |
| 2019-12-10 | BIOTRONIK INC. | $264 | Research payment | Cash or cash equivalent | Sentus Device, Cardiology/Vascular Diseases | QP ExCELs | 2019 |
| 2019-12-10 | BIOTRONIK INC. | $256 | Research payment | Cash or cash equivalent | BIO-LIBRA | 2019 | |
| 2019-12-10 | BIOTRONIK INC. | $256 | Research payment | Cash or cash equivalent | BIO-LIBRA | 2019 | |
| 2019-12-10 | BIOTRONIK INC. | $216 | Research payment | Cash or cash equivalent | Sentus Device, Cardiology/Vascular Diseases | QP ExCELs | 2019 |
| 2019-12-10 | BIOTRONIK INC. | $193 | Research payment | Cash or cash equivalent | BIO-LIBRA | 2019 | |
| 2019-12-10 | BIOTRONIK INC. | $193 | Research payment | Cash or cash equivalent | BIO-LIBRA | 2019 | |
| 2019-12-10 | BIOTRONIK INC. | $193 | Research payment | Cash or cash equivalent | BIO-LIBRA | 2019 | |
| 2019-12-10 | BIOTRONIK INC. | $193 | Research payment | Cash or cash equivalent | BIO-LIBRA | 2019 | |
| 2019-12-10 | BIOTRONIK INC. | $193 | Research payment | Cash or cash equivalent | BIO-LIBRA | 2019 | |
| 2019-12-10 | BIOTRONIK INC. | $186 | Research payment | Cash or cash equivalent | BIO-LIBRA | 2019 | |
| 2019-12-10 | BIOTRONIK INC. | $186 | Research payment | Cash or cash equivalent | BIO-LIBRA | 2019 | |
| 2019-12-10 | BIOTRONIK INC. | $138 | Research payment | Cash or cash equivalent | Sentus Device, Cardiology/Vascular Diseases | QP ExCELs | 2019 |
| 2019-12-10 | BIOTRONIK INC. | $121 | Research payment | Cash or cash equivalent | Sentus Device, Cardiology/Vascular Diseases | QP ExCELs | 2019 |
| 2019-12-10 | BIOTRONIK INC. | $113 | Research payment | Cash or cash equivalent | Sentus Device, Cardiology/Vascular Diseases | QP ExCELs | 2019 |
| 2019-12-10 | BIOTRONIK INC. | $113 | Research payment | Cash or cash equivalent | Sentus Device, Cardiology/Vascular Diseases | QP ExCELs | 2019 |
| 2019-12-10 | BIOTRONIK INC. | $84 | Research payment | Cash or cash equivalent | BIO-LIBRA | 2019 | |
| 2019-12-10 | BIOTRONIK INC. | $84 | Research payment | Cash or cash equivalent | BIO-LIBRA | 2019 | |
| 2019-12-10 | BIOTRONIK INC. | $48 | Research payment | Cash or cash equivalent | Sentus Device, Cardiology/Vascular Diseases | QP ExCELs | 2019 |
| 2019-12-10 | BIOTRONIK INC. | $39 | Research payment | Cash or cash equivalent | Sentus Device, Cardiology/Vascular Diseases | QP ExCELs | 2019 |
| 2019-12-10 | BIOTRONIK INC. | $39 | Research payment | Cash or cash equivalent | Sentus Device, Cardiology/Vascular Diseases | QP ExCELs | 2019 |
| 2019-12-10 | BIOTRONIK INC. | $39 | Research payment | Cash or cash equivalent | Sentus Device, Cardiology/Vascular Diseases | QP ExCELs | 2019 |
| 2019-12-10 | BIOTRONIK INC. | $39 | Research payment | Cash or cash equivalent | Sentus Device, Cardiology/Vascular Diseases | QP ExCELs | 2019 |
| 2019-12-10 | BIOTRONIK INC. | $39 | Research payment | Cash or cash equivalent | Sentus Device, Cardiology/Vascular Diseases | QP ExCELs | 2019 |
| 2019-12-10 | BIOTRONIK INC. | $39 | Research payment | Cash or cash equivalent | Sentus Device, Cardiology/Vascular Diseases | QP ExCELs | 2019 |
| 2019-12-10 | BIOTRONIK INC. | $24 | Research payment | Cash or cash equivalent | Sentus Device, Cardiology/Vascular Diseases | QP ExCELs | 2019 |
| 2019-12-10 | BIOTRONIK INC. | $21 | Research payment | Cash or cash equivalent | BIO-LIBRA | 2019 | |
| 2019-12-10 | BIOTRONIK INC. | $21 | Research payment | Cash or cash equivalent | BIO-LIBRA | 2019 | |
| 2019-12-10 | BIOTRONIK INC. | $21 | Research payment | Cash or cash equivalent | BIO-LIBRA | 2019 | |
| 2019-12-10 | BIOTRONIK INC. | $21 | Research payment | Cash or cash equivalent | BIO-LIBRA | 2019 | |
| 2019-12-10 | BIOTRONIK INC. | $21 | Research payment | Cash or cash equivalent | BIO-LIBRA | 2019 | |
| 2019-12-10 | BIOTRONIK INC. | $21 | Research payment | Cash or cash equivalent | BIO-LIBRA | 2019 | |
| 2019-12-10 | BIOTRONIK INC. | $21 | Research payment | Cash or cash equivalent | BIO-LIBRA | 2019 | |
| 2019-12-10 | BIOTRONIK INC. | $21 | Research payment | Cash or cash equivalent | BIO-LIBRA | 2019 | |
| 2019-12-10 | BIOTRONIK INC. | $21 | Research payment | Cash or cash equivalent | BIO-LIBRA | 2019 | |
| 2019-12-10 | BIOTRONIK INC. | $21 | Research payment | Cash or cash equivalent | BIO-LIBRA | 2019 | |
| 2019-12-10 | BIOTRONIK INC. | $21 | Research payment | Cash or cash equivalent | BIO-LIBRA | 2019 | |
| 2019-12-05 | CSL Behring | $5,518 | Research payment | Cash or cash equivalent | Study to Investigate CSL112 in Subjects With Acute Coronary Syndrome AEGIS-II | 2019 | |
| 2019-12-05 | CSL Behring | $450 | Research payment | Cash or cash equivalent | Study to Investigate CSL112 in Subjects With Acute Coronary Syndrome AEGIS-II | 2019 | |
| 2019-12-04 | Medtronic MiniMed, Inc. | $1,100 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Minimed 670G System Device, Durable Pump | 2019 | |
| 2019-12-04 | Tandem Diabetes Care, Inc. | $400 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | t-slim insulin pump Device, Endocrinology | 2019 | |
| 2019-12-04 | Tandem Diabetes Care, Inc. | $250 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | t-slim insulin pump Device, Endocrinology | 2019 | |
| 2019-11-28 | PFIZER INC. | $564 | Research payment | Cash or cash equivalent | XELJANZ Drug, GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | PHASE 3B4 RANDOMIZED SAFETY ENDPOINT STUDY OF 2 DOSES OF TOFACITINIB IN COMPARISON TO A TUMOR NECROSIS FACTOR TNF INHIBI | 2019 |
| 2019-11-26 | ABBVIE INC. | $10,376 | Research payment | Cash or cash equivalent | Rinvoq Biological, Immunology | M15-572 | 2019 |
| 2019-11-25 | SANOFI US SERVICES INC. | $2,781 | Research payment | Cash or cash equivalent | SAR439977 Drug | A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Effect of Efpeglenatid | 2019 |
| 2019-11-22 | Kowa Research Institute, Inc. | $4,279 | Research payment | Cash or cash equivalent | Drug | K-877-302 | 2019 |
| 2019-11-21 | Eli Lilly and Company | $1,067 | Research payment | In-kind items and services | TALTZ Drug, Immunology | A MULTICENTER LONG-TERM EXTENSION STUDY OF 104 WEEKS INCLUDING A DOUBLE BLIND PLACEBO CONTROLLED 40 WEEK RANDOMIZED WITH | 2019 |
| 2019-11-19 | Sterilmed, Inc. | $371 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2019 | ||
| 2019-11-13 | Amgen Inc. | $26,728 | Research payment | Cash or cash equivalent | Study to Assess the Effect of Omecamtiv Mecarbil on Exercise Capacity in Subjects With Heart Failure (METEORIC-HF) | 2019 | |
| 2019-11-13 | BIOTRONIK INC. | $750 | Research payment | Cash or cash equivalent | Plexa Device, Cardiology/Vascular Diseases | Plexa | 2019 |
| 2019-11-08 | Incyte Corporation | $102 | Research payment | Cash or cash equivalent | PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBRO | 2019 | |
| 2019-11-08 | Incyte Corporation | $1 | Research payment | Cash or cash equivalent | PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBRO | 2019 | |
| 2019-11-07 | CSL Behring | $8,335 | Research payment | Cash or cash equivalent | Study to Investigate CSL112 in Subjects With Acute Coronary Syndrome AEGIS-II | 2019 | |
| 2019-11-07 | Incyte Corporation | $1,154 | Research payment | Cash or cash equivalent | PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBRO | 2019 | |
| 2019-11-07 | CSL Behring | $200 | Research payment | Cash or cash equivalent | Study to Investigate CSL112 in Subjects With Acute Coronary Syndrome AEGIS-II | 2019 | |
| 2019-11-06 | BIOTRONIK INC. | $289 | Research payment | Cash or cash equivalent | Sentus Device, Cardiology/Vascular Diseases | QP ExCELs | 2019 |
| 2019-11-06 | BIOTRONIK INC. | $289 | Research payment | Cash or cash equivalent | Sentus Device, Cardiology/Vascular Diseases | QP ExCELs | 2019 |
| 2019-11-06 | BIOTRONIK INC. | $289 | Research payment | Cash or cash equivalent | Sentus Device, Cardiology/Vascular Diseases | QP ExCELs | 2019 |
| 2019-11-06 | BIOTRONIK INC. | $113 | Research payment | Cash or cash equivalent | Sentus Device, Cardiology/Vascular Diseases | QP ExCELs | 2019 |
| 2019-11-06 | BIOTRONIK INC. | $39 | Research payment | Cash or cash equivalent | Sentus Device, Cardiology/Vascular Diseases | QP ExCELs | 2019 |
| 2019-11-06 | BIOTRONIK INC. | $39 | Research payment | Cash or cash equivalent | Sentus Device, Cardiology/Vascular Diseases | QP ExCELs | 2019 |
| 2019-11-06 | BIOTRONIK INC. | $39 | Research payment | Cash or cash equivalent | Sentus Device, Cardiology/Vascular Diseases | QP ExCELs | 2019 |
| 2019-11-04 | SANOFI US SERVICES INC. | $2,813 | Research payment | Cash or cash equivalent | SAR439977 Drug | A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Effect of Efpeglenatid | 2019 |
| 2019-11-01 | ABBVIE INC. | $30,820 | Research payment | Cash or cash equivalent | Rinvoq Biological, Immunology | M15-572 | 2019 |
| 2019-10-28 | SANOFI US SERVICES INC. | $3,522 | Research payment | Cash or cash equivalent | SAR439977 Drug | A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Effect of Efpeglenatid | 2019 |
| 2019-10-24 | Kowa Research Institute, Inc. | $2,486 | Research payment | Cash or cash equivalent | Drug | K-877-302 | 2019 |
| 2019-10-23 | PFIZER INC. | $2,256 | Research payment | Cash or cash equivalent | XELJANZ Drug, GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | PHASE 3B4 RANDOMIZED SAFETY ENDPOINT STUDY OF 2 DOSES OF TOFACITINIB IN COMPARISON TO A TUMOR NECROSIS FACTOR TNF INHIBI | 2019 |
| 2019-10-23 | Sterilmed, Inc. | $198 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2019 | ||
| 2019-10-22 | CSL Behring | $2,700 | Research payment | Cash or cash equivalent | Study to Investigate CSL112 in Subjects With Acute Coronary Syndrome AEGIS-II | 2019 | |
| 2019-10-17 | Mylan Pharmaceuticals Inc. | $1,200 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | Perforomist Drug, Respiratory and Allergy | 2019 | |
| 2019-10-16 | Incyte Corporation | $500 | Research payment | Cash or cash equivalent | PROSPECTIVE, NON INTERVENTIONAL STUDY OF DISEASE PROGRESSION AND TREATMENT OF PATIENTS WITH POLYCYTHEMIA VERA IN UNITED | 2019 | |
| 2019-10-15 | SANOFI US SERVICES INC. | $4,276 | Research payment | Cash or cash equivalent | SAR439977 Drug | A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Effect of Efpeglenatid | 2019 |
| 2019-10-10 | CSL Behring | $4,689 | Research payment | Cash or cash equivalent | Study to Investigate CSL112 in Subjects With Acute Coronary Syndrome AEGIS-II | 2019 | |
| 2019-10-10 | Bayer Healthcare Pharmaceuticals Inc. | $1,000 | Research payment | Cash or cash equivalent | Non-Covered | Vericiguat in HFpEF | 2019 |
| 2019-10-10 | CSL Behring | $200 | Research payment | Cash or cash equivalent | Study to Investigate CSL112 in Subjects With Acute Coronary Syndrome AEGIS-II | 2019 | |
| 2019-10-08 | BIOTRONIK INC. | $300 | Research payment | Cash or cash equivalent | Plexa Device, Cardiology/Vascular Diseases | Plexa | 2019 |
| 2019-10-08 | BIOTRONIK INC. | $300 | Research payment | Cash or cash equivalent | Plexa Device, Cardiology/Vascular Diseases | Plexa | 2019 |
| 2019-10-08 | BIOTRONIK INC. | $300 | Research payment | Cash or cash equivalent | Plexa Device, Cardiology/Vascular Diseases | Plexa | 2019 |
| 2019-10-08 | BIOTRONIK INC. | $289 | Research payment | Cash or cash equivalent | Sentus Device, Cardiology/Vascular Diseases | QP ExCELs | 2019 |
| 2019-10-08 | BIOTRONIK INC. | $251 | Research payment | Cash or cash equivalent | Plexa Device, Cardiology/Vascular Diseases | Plexa | 2019 |
| 2019-10-08 | BIOTRONIK INC. | $130 | Research payment | Cash or cash equivalent | Plexa Device, Cardiology/Vascular Diseases | Plexa | 2019 |
| 2019-10-08 | BIOTRONIK INC. | $130 | Research payment | Cash or cash equivalent | Plexa Device, Cardiology/Vascular Diseases | Plexa | 2019 |
| 2019-10-08 | BIOTRONIK INC. | $130 | Research payment | Cash or cash equivalent | Plexa Device, Cardiology/Vascular Diseases | Plexa | 2019 |
| 2019-10-08 | BIOTRONIK INC. | $130 | Research payment | Cash or cash equivalent | Plexa Device, Cardiology/Vascular Diseases | Plexa | 2019 |
| 2019-10-08 | BIOTRONIK INC. | $130 | Research payment | Cash or cash equivalent | Plexa Device, Cardiology/Vascular Diseases | Plexa | 2019 |
| 2019-10-08 | BIOTRONIK INC. | $39 | Research payment | Cash or cash equivalent | Sentus Device, Cardiology/Vascular Diseases | QP ExCELs | 2019 |
| 2019-10-02 | SANOFI US SERVICES INC. | $2,781 | Research payment | Cash or cash equivalent | SAR439977 Drug | A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Effect of Efpeglenatid | 2019 |
| 2019-10-01 | Kowa Research Institute, Inc. | $4,872 | Research payment | Cash or cash equivalent | Drug | K-877-302 | 2019 |
| 2019-10-01 | Amgen Inc. | $103 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | In-kind items and services | IMLYGIC Biological, Oncology | 2019 | |
| 2019-09-30 | Chiesi USA, Inc. | $1,200 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | KENGREAL Drug, CARDIOVASCULAR | 2019 | |
| 2019-09-27 | SANOFI-AVENTIS U.S. LLC | $1,200 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | MULTAQ Drug, CARDIOVASCULAR | 2019 | |
| 2019-09-19 | PFIZER INC. | $1,200 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | VYNDAQEL Drug, CARDIOVASCULAR | 2019 | |
| 2019-09-18 | PFIZER INC. | $1,692 | Research payment | Cash or cash equivalent | XELJANZ Drug, GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | PHASE 3B4 RANDOMIZED SAFETY ENDPOINT STUDY OF 2 DOSES OF TOFACITINIB IN COMPARISON TO A TUMOR NECROSIS FACTOR TNF INHIBI | 2019 |
| 2019-09-18 | Allergan, Inc. | $1,500 | Education | Cash or cash equivalent | 2019 | ||
| 2019-09-17 | CSL Behring | $17,060 | Research payment | Cash or cash equivalent | Study to Investigate CSL112 in Subjects With Acute Coronary Syndrome AEGIS-II | 2019 | |
| 2019-09-17 | Intuitive Surgical, Inc. | $3,180 | Gift | In-kind items and services | Da Vinci Surgical System Device, SURGERY | 2019 | |
| 2019-09-17 | Intuitive Surgical, Inc. | $2,970 | Gift | In-kind items and services | Da Vinci Surgical System Device, SURGERY | 2019 | |
| 2019-09-17 | CSL Behring | $600 | Research payment | Cash or cash equivalent | Study to Investigate CSL112 in Subjects With Acute Coronary Syndrome AEGIS-II | 2019 | |
| 2019-09-16 | SANOFI US SERVICES INC. | $1,300 | Research payment | Cash or cash equivalent | SAR439977 Drug | A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Effect of Efpeglenatid | 2019 |
| 2019-09-16 | SANOFI US SERVICES INC. | $226 | Research payment | Cash or cash equivalent | SAR439977 Drug | A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Effect of Efpeglenatid | 2019 |
| 2019-09-12 | Incyte Corporation | $6,099 | Research payment | Cash or cash equivalent | PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBRO | 2019 | |
| 2019-09-10 | Eli Lilly and Company | $746 | Research payment | In-kind items and services | A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, PHASE 3 STUDY OF BARICITINIB IN PATIENTS WITH SYSTEMIC L | 2019 | |
| 2019-09-10 | BIOTRONIK INC. | $373 | Research payment | Cash or cash equivalent | Sentus Device, Cardiology/Vascular Diseases | QP ExCELs | 2019 |
| 2019-09-10 | BIOTRONIK INC. | $373 | Research payment | Cash or cash equivalent | Sentus Device, Cardiology/Vascular Diseases | QP ExCELs | 2019 |
| 2019-09-10 | BIOTRONIK INC. | $338 | Research payment | Cash or cash equivalent | Sentus Device, Cardiology/Vascular Diseases | QP ExCELs | 2019 |
| 2019-09-10 | BIOTRONIK INC. | $289 | Research payment | Cash or cash equivalent | Sentus Device, Cardiology/Vascular Diseases | QP ExCELs | 2019 |
| 2019-09-10 | BIOTRONIK INC. | $289 | Research payment | Cash or cash equivalent | Sentus Device, Cardiology/Vascular Diseases | QP ExCELs | 2019 |
| 2019-09-10 | BIOTRONIK INC. | $289 | Research payment | Cash or cash equivalent | Sentus Device, Cardiology/Vascular Diseases | QP ExCELs | 2019 |
| 2019-09-10 | BIOTRONIK INC. | $289 | Research payment | Cash or cash equivalent | Sentus Device, Cardiology/Vascular Diseases | QP ExCELs | 2019 |
| 2019-09-10 | BIOTRONIK INC. | $289 | Research payment | Cash or cash equivalent | Sentus Device, Cardiology/Vascular Diseases | QP ExCELs | 2019 |
| 2019-09-10 | BIOTRONIK INC. | $289 | Research payment | Cash or cash equivalent | Sentus Device, Cardiology/Vascular Diseases | QP ExCELs | 2019 |
| 2019-09-10 | BIOTRONIK INC. | $289 | Research payment | Cash or cash equivalent | Sentus Device, Cardiology/Vascular Diseases | QP ExCELs | 2019 |
| 2019-09-10 | BIOTRONIK INC. | $289 | Research payment | Cash or cash equivalent | Sentus Device, Cardiology/Vascular Diseases | QP ExCELs | 2019 |
| 2019-09-10 | BIOTRONIK INC. | $289 | Research payment | Cash or cash equivalent | Sentus Device, Cardiology/Vascular Diseases | QP ExCELs | 2019 |
| 2019-09-10 | BIOTRONIK INC. | $289 | Research payment | Cash or cash equivalent | Sentus Device, Cardiology/Vascular Diseases | QP ExCELs | 2019 |
| 2019-09-10 | BIOTRONIK INC. | $256 | Research payment | Cash or cash equivalent | BIO-LIBRA | 2019 | |
| 2019-09-10 | BIOTRONIK INC. | $227 | Research payment | Cash or cash equivalent | Plexa Device, Cardiology/Vascular Diseases | Plexa | 2019 |
| 2019-09-10 | BIOTRONIK INC. | $227 | Research payment | Cash or cash equivalent | Plexa Device, Cardiology/Vascular Diseases | Plexa | 2019 |
| 2019-09-10 | BIOTRONIK INC. | $193 | Research payment | Cash or cash equivalent | BIO-LIBRA | 2019 | |
| 2019-09-10 | BIOTRONIK INC. | $186 | Research payment | Cash or cash equivalent | BIO-LIBRA | 2019 | |
| 2019-09-10 | BIOTRONIK INC. | $130 | Research payment | Cash or cash equivalent | Plexa Device, Cardiology/Vascular Diseases | Plexa | 2019 |
| 2019-09-10 | BIOTRONIK INC. | $130 | Research payment | Cash or cash equivalent | Plexa Device, Cardiology/Vascular Diseases | Plexa | 2019 |
| 2019-09-10 | BIOTRONIK INC. | $130 | Research payment | Cash or cash equivalent | Plexa Device, Cardiology/Vascular Diseases | Plexa | 2019 |
| 2019-09-10 | BIOTRONIK INC. | $130 | Research payment | Cash or cash equivalent | Plexa Device, Cardiology/Vascular Diseases | Plexa | 2019 |
| 2019-09-10 | BIOTRONIK INC. | $130 | Research payment | Cash or cash equivalent | Plexa Device, Cardiology/Vascular Diseases | Plexa | 2019 |
| 2019-09-10 | BIOTRONIK INC. | $130 | Research payment | Cash or cash equivalent | Plexa Device, Cardiology/Vascular Diseases | Plexa | 2019 |
| 2019-09-10 | BIOTRONIK INC. | $130 | Research payment | Cash or cash equivalent | Plexa Device, Cardiology/Vascular Diseases | Plexa | 2019 |
| 2019-09-10 | BIOTRONIK INC. | $130 | Research payment | Cash or cash equivalent | Plexa Device, Cardiology/Vascular Diseases | Plexa | 2019 |
| 2019-09-10 | BIOTRONIK INC. | $130 | Research payment | Cash or cash equivalent | Plexa Device, Cardiology/Vascular Diseases | Plexa | 2019 |
| 2019-09-10 | BIOTRONIK INC. | $130 | Research payment | Cash or cash equivalent | Plexa Device, Cardiology/Vascular Diseases | Plexa | 2019 |
| 2019-09-10 | BIOTRONIK INC. | $113 | Research payment | Cash or cash equivalent | Sentus Device, Cardiology/Vascular Diseases | QP ExCELs | 2019 |
| 2019-09-10 | BIOTRONIK INC. | $113 | Research payment | Cash or cash equivalent | Sentus Device, Cardiology/Vascular Diseases | QP ExCELs | 2019 |
| 2019-09-10 | BIOTRONIK INC. | $113 | Research payment | Cash or cash equivalent | Sentus Device, Cardiology/Vascular Diseases | QP ExCELs | 2019 |
| 2019-09-10 | BIOTRONIK INC. | $84 | Research payment | Cash or cash equivalent | BIO-LIBRA | 2019 | |
| 2019-09-10 | BIOTRONIK INC. | $48 | Research payment | Cash or cash equivalent | Plexa Device, Cardiology/Vascular Diseases | Plexa | 2019 |
| 2019-09-10 | BIOTRONIK INC. | $48 | Research payment | Cash or cash equivalent | Plexa Device, Cardiology/Vascular Diseases | Plexa | 2019 |
| 2019-09-10 | BIOTRONIK INC. | $48 | Research payment | Cash or cash equivalent | Plexa Device, Cardiology/Vascular Diseases | Plexa | 2019 |
| 2019-09-10 | BIOTRONIK INC. | $48 | Research payment | Cash or cash equivalent | Plexa Device, Cardiology/Vascular Diseases | Plexa | 2019 |
| 2019-09-10 | BIOTRONIK INC. | $48 | Research payment | Cash or cash equivalent | Plexa Device, Cardiology/Vascular Diseases | Plexa | 2019 |
| 2019-09-10 | BIOTRONIK INC. | $39 | Research payment | Cash or cash equivalent | Sentus Device, Cardiology/Vascular Diseases | QP ExCELs | 2019 |
| 2019-09-10 | BIOTRONIK INC. | $39 | Research payment | Cash or cash equivalent | Sentus Device, Cardiology/Vascular Diseases | QP ExCELs | 2019 |
| 2019-09-10 | BIOTRONIK INC. | $39 | Research payment | Cash or cash equivalent | Sentus Device, Cardiology/Vascular Diseases | QP ExCELs | 2019 |
| 2019-09-10 | BIOTRONIK INC. | $39 | Research payment | Cash or cash equivalent | Sentus Device, Cardiology/Vascular Diseases | QP ExCELs | 2019 |
| 2019-09-10 | BIOTRONIK INC. | $39 | Research payment | Cash or cash equivalent | Sentus Device, Cardiology/Vascular Diseases | QP ExCELs | 2019 |
| 2019-09-10 | BIOTRONIK INC. | $39 | Research payment | Cash or cash equivalent | Sentus Device, Cardiology/Vascular Diseases | QP ExCELs | 2019 |
| 2019-09-10 | BIOTRONIK INC. | $39 | Research payment | Cash or cash equivalent | Sentus Device, Cardiology/Vascular Diseases | QP ExCELs | 2019 |
| 2019-09-10 | BIOTRONIK INC. | $39 | Research payment | Cash or cash equivalent | Sentus Device, Cardiology/Vascular Diseases | QP ExCELs | 2019 |
| 2019-09-10 | BIOTRONIK INC. | $24 | Research payment | Cash or cash equivalent | Plexa Device, Cardiology/Vascular Diseases | Plexa | 2019 |
| 2019-09-10 | BIOTRONIK INC. | $24 | Research payment | Cash or cash equivalent | Plexa Device, Cardiology/Vascular Diseases | Plexa | 2019 |
| 2019-09-10 | BIOTRONIK INC. | $21 | Research payment | Cash or cash equivalent | BIO-LIBRA | 2019 | |
| 2019-09-10 | BIOTRONIK INC. | $21 | Research payment | Cash or cash equivalent | BIO-LIBRA | 2019 | |
| 2019-09-10 | BIOTRONIK INC. | $21 | Research payment | Cash or cash equivalent | BIO-LIBRA | 2019 | |
| 2019-09-10 | BIOTRONIK INC. | $21 | Research payment | Cash or cash equivalent | BIO-LIBRA | 2019 | |
| 2019-09-05 | ABBVIE INC. | $952 | Research payment | Cash or cash equivalent | Skyrizi Biological, Immunology | M15-998 | 2019 |
| 2019-09-04 | Sterilmed, Inc. | $284 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2019 | ||
| 2019-09-03 | SANOFI US SERVICES INC. | $1,850 | Research payment | Cash or cash equivalent | SAR439977 Drug | A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Effect of Efpeglenatid | 2019 |
| 2019-09-01 | Amgen Inc. | $103 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | In-kind items and services | IMLYGIC Biological, Oncology | 2019 | |
| 2019-08-28 | PFIZER INC. | $689 | Research payment | Cash or cash equivalent | XELJANZ Drug, GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | PHASE 3B4 RANDOMIZED SAFETY ENDPOINT STUDY OF 2 DOSES OF TOFACITINIB IN COMPARISON TO A TUMOR NECROSIS FACTOR TNF INHIBI | 2019 |
| 2019-08-26 | SANOFI US SERVICES INC. | $1,839 | Research payment | Cash or cash equivalent | SAR439977 Drug | A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Effect of Efpeglenatid | 2019 |
| 2019-08-25 | Genentech USA, Inc. | $1,200 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | Esbriet Biological, Immunology | 2019 | |
| 2019-08-22 | Ipsen Biopharmaceuticals, Inc | $1,500 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | SOMATULINE DEPOT Drug, Oncology/Endocrinology | 2019 | |
| 2019-08-19 | PFIZER INC. | $1,200 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | ELIQUIS Drug, CARDIOVASCULAR;METABOLIC DISEASE | 2019 | |
| 2019-08-19 | Amgen Inc. | $1,200 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | Corlanor Drug, Cardiology | 2019 | |
| 2019-08-15 | Tandem Diabetes Care, Inc. | $400 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | t-slim insulin pump Device, Endocrinology | 2019 | |
| 2019-08-13 | ABBVIE INC. | $11,350 | Research payment | Cash or cash equivalent | Skyrizi Biological, Immunology | M15-998 | 2019 |
| 2019-08-13 | CSL Behring | $1,639 | Research payment | Cash or cash equivalent | Study to Investigate CSL112 in Subjects With Acute Coronary Syndrome AEGIS-II | 2019 | |
| 2019-08-13 | BIOTRONIK INC. | $299 | Research payment | Cash or cash equivalent | BIO-LIBRA | 2019 | |
| 2019-08-13 | BIOTRONIK INC. | $289 | Research payment | Cash or cash equivalent | Sentus Device, Cardiology/Vascular Diseases | QP ExCELs | 2019 |
| 2019-08-13 | BIOTRONIK INC. | $289 | Research payment | Cash or cash equivalent | Sentus Device, Cardiology/Vascular Diseases | QP ExCELs | 2019 |
| 2019-08-13 | BIOTRONIK INC. | $289 | Research payment | Cash or cash equivalent | Sentus Device, Cardiology/Vascular Diseases | QP ExCELs | 2019 |
| 2019-08-13 | BIOTRONIK INC. | $264 | Research payment | Cash or cash equivalent | Sentus Device, Cardiology/Vascular Diseases | QP ExCELs | 2019 |
| 2019-08-13 | BIOTRONIK INC. | $264 | Research payment | Cash or cash equivalent | Sentus Device, Cardiology/Vascular Diseases | QP ExCELs | 2019 |
| 2019-08-13 | BIOTRONIK INC. | $256 | Research payment | Cash or cash equivalent | BIO-LIBRA | 2019 | |
| 2019-08-13 | BIOTRONIK INC. | $256 | Research payment | Cash or cash equivalent | BIO-LIBRA | 2019 | |
| 2019-08-13 | BIOTRONIK INC. | $256 | Research payment | Cash or cash equivalent | BIO-LIBRA | 2019 | |
| 2019-08-13 | BIOTRONIK INC. | $256 | Research payment | Cash or cash equivalent | BIO-LIBRA | 2019 | |
| 2019-08-13 | BIOTRONIK INC. | $227 | Research payment | Cash or cash equivalent | Plexa Device, Cardiology/Vascular Diseases | Plexa | 2019 |
| 2019-08-13 | BIOTRONIK INC. | $216 | Research payment | Cash or cash equivalent | Sentus Device, Cardiology/Vascular Diseases | QP ExCELs | 2019 |
| 2019-08-13 | BIOTRONIK INC. | $216 | Research payment | Cash or cash equivalent | Sentus Device, Cardiology/Vascular Diseases | QP ExCELs | 2019 |
| 2019-08-13 | BIOTRONIK INC. | $193 | Research payment | Cash or cash equivalent | BIO-LIBRA | 2019 | |
| 2019-08-13 | BIOTRONIK INC. | $193 | Research payment | Cash or cash equivalent | BIO-LIBRA | 2019 | |
| 2019-08-13 | BIOTRONIK INC. | $193 | Research payment | Cash or cash equivalent | BIO-LIBRA | 2019 | |
| 2019-08-13 | BIOTRONIK INC. | $193 | Research payment | Cash or cash equivalent | BIO-LIBRA | 2019 | |
| 2019-08-13 | BIOTRONIK INC. | $186 | Research payment | Cash or cash equivalent | BIO-LIBRA | 2019 | |
| 2019-08-13 | BIOTRONIK INC. | $186 | Research payment | Cash or cash equivalent | BIO-LIBRA | 2019 | |
| 2019-08-13 | BIOTRONIK INC. | $186 | Research payment | Cash or cash equivalent | BIO-LIBRA | 2019 |
The latest 200 records of 650.
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Kalispell, MT, county Flathead County, MT, state Montana; placed by its city name.
| Measure | Place (city or town) Kalispell, MT | County Flathead County, MT | State Montana |
|---|---|---|---|
| Population B01003 | 28,504 | 110,695 | 1,116,875 |
| Population, 2020 census P1 | 24,558 | 104,357 | 1,084,225 |
| Median age B01002 | 36.2 | 42.2 | 40.4 |
| Under 18 B01001 | 23.8% | 21.6% | 21.0% |
| 65 and over B01001 | 19.2% | 21.1% | 20.1% |
| Households B11001 | 11,795 | 44,233 | 458,859 |
| Foreign born B05002 | 3.5% | 2.8% | 2.3% |
| Median household income B19013 | $63,415 | $73,925 | $72,509 |
| Median family income B19113 | $89,279 | $93,578 | $92,794 |
| Per capita income B19301 | $36,679 | $41,557 | $41,711 |
| Poverty rate B17001 | 10.0% | 9.3% | 11.5% |
| Unemployment rate B23025 | 2.6% | 2.9% | 3.6% |
| Civilian labor force B23025 | 14,539 | 55,909 | 568,568 |
| Mean commute (minutes) B08013 | 14.9 | 19.6 | 19.1 |
| Bachelor's degree or higher B15003 | 34.8% | 37.2% | 35.2% |
| Housing units B25001 | 12,267 | 51,680 | 528,419 |
| Owner-occupied B25003 | 55.1% | 72.4% | 69.2% |
| Renters B25003 | 44.9% | 27.6% | 30.8% |
| Median home value B25077 | $428,000 | $535,500 | $375,800 |
| Median gross rent B25064 | $1,078 | $1,142 | $1,081 |
| White, not Hispanic B03002 | 87.4% | 90.0% | 83.6% |
| Black B03002 | 0.1% | 0.2% | 0.4% |
| Hispanic or Latino B03002 | 5.4% | 3.7% | 4.6% |
| Asian B03002 | 1.4% | 0.8% | 0.8% |
| American Indian and Alaska Native B03002 | 0.9% | 0.8% | 5.3% |
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Kalispell, MT.
Comments